Literature DB >> 9871547

L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor.

P E Sanderson1, K J Cutrona, B D Dorsey, D L Dyer, C M McDonough, A M Naylor-Olsen, I W Chen, Z Chen, J J Cook, S J Gardell, J A Krueger, S D Lewis, J H Lin, B J Lucas, E A Lyle, J J Lynch, M T Stranieri, K Vastag, J A Shafer, J P Vacca.   

Abstract

Replacement of the amidinopiperidine P1 group of 3-benzylsulfonylamino-6-methyl-2-pyridinone acetamide thrombin inhibitor L-373,890 (2) with a mildly basic 5-linked 2-amino-6-methylpyridine results in an equipotent compound L-374,087 (5, Ki = 0.5 nM). Compound 5 is highly selective for thrombin over trypsin, is efficacious in the rat ferric chloride model of arterial thrombosis and is orally bioavailable in dogs and cynomolgus monkeys. The structural basis for the critical importance of both methyl groups in 5 was confirmed by X-ray crystallography.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871547     DOI: 10.1016/s0960-894x(98)00117-6

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Thrombin inhibitors with novel P1 binding pocket functionality: free energy of binding analysis.

Authors:  Gregor Mlinsek; Marko Oblak; Milan Hodoscek; Tom Solmajer
Journal:  J Mol Model       Date:  2006-09-30       Impact factor: 1.810

2.  Solvent interaction energy calculations on molecular dynamics trajectories: increasing the efficiency using systematic frame selection.

Authors:  Markus A Lill; Jared J Thompson
Journal:  J Chem Inf Model       Date:  2011-09-15       Impact factor: 4.956

3.  Zinc (II)-Mediated Selective O-Benzylation of 2-Oxo-1,2-Dihydropyridines Systems.

Authors:  Qifan Zhou; Fangyu Du; Xinjie Liang; Wenqiang Liu; Ting Fang; Guoliang Chen
Journal:  Molecules       Date:  2018-07-20       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.